Tobacco quitting support for people living with HIV in Kisumu County, Kenya
Integrating tobacco use cessation into HIV Care and Treatment in Ministry of Health Facilities in Kisumu County, Kenya
This project brings tobacco‑cessation help into HIV clinics so people living with HIV in Kisumu can get counseling and support to quit tobacco.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11174528 on NIH RePORTER |
What this research studies
If you get HIV care at participating clinics, staff will ask about tobacco use and offer treatment following Kenya's national tobacco‑cessation guidelines. Clinic teams will be trained to provide brief counseling, referral, and possible medication options, and they will follow up during routine HIV visits. The program is being rolled out through existing Ministry of Health HIV clinics supported by the FACES partnership. Researchers will track how many people accept support and whether they are able to stop using tobacco over time.
Who could benefit from this research
Good fit: Adults living with HIV who currently use tobacco and receive care at participating Ministry of Health HIV clinics in Kisumu County, Kenya.
Not a fit: People who do not use tobacco or who do not attend the participating clinics are unlikely to be able to take part or benefit from this project.
Why it matters
Potential benefit: If successful, this work could help people living with HIV quit tobacco and lower their risk of tobacco‑related illness and death.
How similar studies have performed: Clinic‑based tobacco cessation programs have helped people quit in other settings, but implementing guideline‑based cessation within Kenyan HIV clinics is relatively new.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Bialous, Stella Aguinaga — University of California, San Francisco
- Study coordinator: Bialous, Stella Aguinaga
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.